Treace(TMCI) - 2025 Q2 - Quarterly Results
Second Quarter 2025 Financial Results Revenue for the second quarter of 2025 was $47.4 million, representing an increase of 7% compared to $44.5 million in the second quarter of 2024. Exhibit 99.1 Treace Medical Concepts Reports Second Quarter 2025 Financial Results Announces Full Market Release of Three New Bunion Technologies PONTE VEDRA, Fla. – August 7, 2025 – Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgi ...